• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加强非洲疫苗和药品制造能力:挑战与展望。

Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives.

机构信息

National Food Safety Authority (NFSA), Aswan, Egypt.

Ministry of Tourism and Antiquities, Aswan, Egypt.

出版信息

EMBO Mol Med. 2022 Aug 8;14(8):e16287. doi: 10.15252/emmm.202216287. Epub 2022 Jun 27.

DOI:10.15252/emmm.202216287
PMID:35758210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9358391/
Abstract

Africa carries a high burden of infectious diseases. Every year, millions of Africans contract tuberculosis, malaria, and many other diseases. Malaria kills hundreds of thousands of children under the age of five years annually. More than 11,000 people died during the 2014-2016 Ebola outbreak in West Africa; still, occasional cases of Ebola, as well as monkeypox, periodically appear in the Democratic Republic of Congo. Since most of the African countries gained their independence during the 1960s, the continent has relied heavily on the outside world for diagnostics, medicines, vaccines, personal protective equipment, and other medical supplies. Africa consumes nearly 25% of the globally produced vaccines but imports 99% and 95% of its vaccines and medicines, respectively. The 55 African countries were not able to ensure the health of 1.3 billion Africans during the COVID-19 pandemic but had to rely on other global initiatives and other countries for help and support. However, the pandemic and the shortage of vaccines may have been the much-needed trigger for this situation to change. "When misfortunes increase, they erase each other." Naguib Mahfouz (1911-2006).

摘要

非洲承担着传染病的沉重负担。每年,数以百万计的非洲人感染结核病、疟疾和许多其他疾病。疟疾每年导致数十万五岁以下儿童死亡。在 2014-2016 年西非埃博拉疫情期间,超过 11000 人死亡;尽管如此,埃博拉病毒和猴痘的偶发病例仍定期出现在刚果民主共和国。自 20 世纪 60 年代大多数非洲国家获得独立以来,该大陆在诊断、药品、疫苗、个人防护设备和其他医疗用品方面严重依赖外部世界。非洲消耗了全球生产的疫苗的近 25%,但分别进口了其疫苗和药品的 99%和 95%。在 COVID-19 大流行期间,55 个非洲国家无法确保 13 亿非洲人的健康,但不得不依靠其他全球倡议和其他国家的帮助和支持。然而,这场大流行和疫苗短缺可能是改变这种状况的急需契机。“当不幸增多时,它们会相互抵消。”纳吉布·马哈福兹(1911-2006)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c989/9358391/f2bae3926e6c/EMMM-14-e16287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c989/9358391/f2bae3926e6c/EMMM-14-e16287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c989/9358391/f2bae3926e6c/EMMM-14-e16287-g001.jpg

相似文献

1
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives.加强非洲疫苗和药品制造能力:挑战与展望。
EMBO Mol Med. 2022 Aug 8;14(8):e16287. doi: 10.15252/emmm.202216287. Epub 2022 Jun 27.
2
Malaria & mRNA Vaccines: A Possible Salvation from One of the Most Relevant Infectious Diseases of the Global South.疟疾与 mRNA 疫苗:一种可能拯救全球南方最相关传染病之一的方法。
Acta Parasitol. 2023 Dec;68(4):916-928. doi: 10.1007/s11686-023-00712-y. Epub 2023 Oct 12.
3
COVID-19: The Current Situation in the Democratic Republic of Congo.COVID-19:刚果民主共和国的现状。
Am J Trop Med Hyg. 2020 Dec;103(6):2168-2170. doi: 10.4269/ajtmh.20-1169. Epub 2020 Oct 9.
4
Conquering the intolerable burden of malaria: what's new, what's needed: a summary.战胜疟疾的沉重负担:新进展与需求总结
Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):1-15.
5
COVID-19 vaccinology landscape in Africa.非洲的 COVID-19 疫苗学领域
Front Immunol. 2022 Dec 5;13:955168. doi: 10.3389/fimmu.2022.955168. eCollection 2022.
6
Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa.利用 COVID-19 疫苗创新和技术在非洲发展可持续疫苗制造能力的机遇和挑战。
Lancet Infect Dis. 2023 Aug;23(8):e288-e300. doi: 10.1016/S1473-3099(22)00878-7. Epub 2023 Jun 5.
7
Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.在刚果民主共和国偏远地区建立埃博拉疫苗试验:挑战、缓解措施和经验教训。
Vaccine. 2022 May 31;40(25):3470-3480. doi: 10.1016/j.vaccine.2022.04.094. Epub 2022 May 9.
8
Description of vaccine clinical trials in Africa: a narrative review.非洲疫苗临床试验描述:叙事性综述。
Hum Vaccin Immunother. 2020 Apr 2;16(4):972-980. doi: 10.1080/21645515.2019.1693720. Epub 2019 Dec 12.
9
COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa.COVID-19 应对准备:撒哈拉以南非洲地区疫苗、疗法和诊断试剂的生产能力。
Global Health. 2021 Mar 3;17(1):24. doi: 10.1186/s12992-021-00668-6.
10
The experience of disproportionate supplies of COVID-19 vaccines to Africa: the need for Africa to decolonize its public health response.非洲 COVID-19 疫苗供应不成比例的经历:非洲需要使公共卫生应对去殖民化。
Pan Afr Med J. 2023 Jan 27;44:54. doi: 10.11604/pamj.2023.44.54.37737. eCollection 2023.

引用本文的文献

1
Plant-based edible vaccines: Can cholera be the case study in Africa?植物源可食用疫苗:霍乱能成为非洲的案例研究对象吗?
J Genet Eng Biotechnol. 2025 Sep;23(3):100527. doi: 10.1016/j.jgeb.2025.100527. Epub 2025 Jun 23.
2
A new era for African health systems: Market shaping and the African Continental Free Trade Area (AfCFTA).非洲卫生系统的新时代:市场塑造与非洲大陆自由贸易区(AfCFTA)
Public Health Chall. 2024 May 7;3(2):e172. doi: 10.1002/puh2.172. eCollection 2024 Jun.
3
Overcoming barriers to medical countermeasures: Strengthening global biosecurity.

本文引用的文献

1
African clinical trial denied access to key COVID drug Paxlovid.非洲一项临床试验被拒绝获取关键新冠药物帕罗韦德。
Nature. 2022 Apr;604(7906):412-413. doi: 10.1038/d41586-022-00919-5.
2
Management of COVID-19 vaccines cold chain logistics: a scoping review.新型冠状病毒肺炎疫苗冷链物流管理:一项范围综述
J Pharm Policy Pract. 2022 Mar 2;15(1):16. doi: 10.1186/s40545-022-00411-5.
3
Africa is going to develop their own health capabilities for future challenges - Correspondence.非洲将发展自身应对未来挑战的卫生能力——通信。
克服医学应对措施的障碍:加强全球生物安全。
Hum Vaccin Immunother. 2025 Dec;21(1):2483043. doi: 10.1080/21645515.2025.2483043. Epub 2025 Mar 25.
4
WHO-listed authorities (WLA) framework: transparent evidence-based approach for promoting regulatory reliance towards increased access to quality-assured medical products.世界卫生组织认可当局(WLA)框架:一种基于证据的透明方法,用于促进监管互认,以增加获得质量保证医疗产品的机会。
Front Med (Lausanne). 2024 Sep 23;11:1467229. doi: 10.3389/fmed.2024.1467229. eCollection 2024.
5
Further analysis of tuberculosis in eight high-burden countries based on the Global Burden of Disease Study 2021 data.基于 2021 年全球疾病负担研究数据对八个高负担国家的结核病进行进一步分析。
Infect Dis Poverty. 2024 Sep 30;13(1):70. doi: 10.1186/s40249-024-01247-8.
6
Addressing the re-emergence and resurgence of vaccine-preventable diseases in Africa: A health equity perspective.解决非洲疫苗可预防疾病的再次出现和死灰复燃:从公平健康视角看问题。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2375081. doi: 10.1080/21645515.2024.2375081. Epub 2024 Jul 9.
7
Building genomic capacity for precision health in Africa.在非洲建立精准健康的基因组能力。
Nat Med. 2024 Jul;30(7):1856-1864. doi: 10.1038/s41591-024-03081-9. Epub 2024 Jul 3.
8
Malaria vaccination in Africa: A mini-review of challenges and opportunities.非洲的疟疾疫苗接种:挑战与机遇的小型综述。
Medicine (Baltimore). 2024 Jun 14;103(24):e38565. doi: 10.1097/MD.0000000000038565.
9
Socio-demographic factors associated with COVID-19 vaccine uptake and refusal among Ugandan women.与乌干达女性中 COVID-19 疫苗接种和拒绝接种相关的社会人口因素。
Global Health. 2023 Sep 6;19(1):68. doi: 10.1186/s12992-023-00968-z.
10
The Urgent Need to Intensify Vaccine Development and Manufacturing in Africa: Lessons from Emerging Pandemics.非洲加强疫苗研发和生产的迫切需求:新发大流行病的教训
Innov Pharm. 2022 Dec 26;13(4). doi: 10.24926/iip.v13i4.5049. eCollection 2022.
Int J Surg. 2022 Mar;99:106585. doi: 10.1016/j.ijsu.2022.106585. Epub 2022 Feb 26.
4
Africa is bringing vaccine manufacturing home.非洲正在将疫苗生产带回本土。
Nature. 2022 Feb;602(7896):184. doi: 10.1038/d41586-022-00335-9.
5
Covid-19: WHO efforts to bring vaccine manufacturing to Africa are undermined by the drug industry, documents show.新冠疫情:文件显示,世界卫生组织将疫苗生产引入非洲的努力受到制药行业的破坏。
BMJ. 2022 Feb 9;376:o304. doi: 10.1136/bmj.o304.
6
Time for Africa to future-proof, starting with COVID-19.非洲应从新冠疫情开始,为未来做好准备。
Lancet Infect Dis. 2022 Feb;22(2):151. doi: 10.1016/S1473-3099(22)00011-1. Epub 2022 Jan 13.
7
Addressing production gaps for vaccines in African countries.解决非洲国家疫苗生产缺口问题。
Bull World Health Organ. 2021 Dec 1;99(12):910-912. doi: 10.2471/BLT.21.287381. Epub 2021 Nov 17.
8
Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.在塞拉利昂埃博拉疫情期间,为 STRIVE 埃博拉疫苗试验快速建立 -60°C 或更低温的冷链能力。
J Infect Dis. 2018 May 18;217(suppl_1):S48-S55. doi: 10.1093/infdis/jix336.